Objectives: Coronary artery bypass grafting (CABG) is the preferred revascularisation option for diabetics with multivessel coronary artery disease, in current guideline recommendations. Not infrequently, coronary artery disease causes minimal symptoms in diabetic patients, so they present late for surgery and this could have implications for clinical outcomes. We sought to examine differences in symptom severity between diabetics and non-diabetics at presentation for CABG, and the impact on in-hospital outcomes. Methods: We retrieved prospectively collected data for all patients who had CABG between January 2000 and December 2022. Perioperative variables were compared between diabetic and non-diabetics. The association between in-hospital major adverse cardiac and cerebrovascular events (MACCE) and perioperative variables was determined using multivariate analysis. Results: Of 10,834 patients, diabetics constituted 24.8% (n = 2687) with mean age 66.4 ± 8.7 years compared to non-diabetics 65.9 ± 9.4, p = 0.02. More diabetics (p < 0.001) had unstable symptoms (31% vs 25%), heart failure (15.5% vs 8.5%), previous myocardial infarction (54.2% vs 46.2%), prior coronary stenting (19% vs 15.8%), left ventricular systolic ejection fraction < 0.5 (33.8% vs 23.8%), triple vessel coronary disease (73.8% vs 70%) and frequently underwent non-elective CABG (32.3% vs 27.6%). Operative mortality (2.3% vs 1.5%, p = 0.004) and MACCE rates (4.7% vs 2.9%, p < 0.001) were higher in diabetics. Diabetes, however, was not an independent predictor of MACCE, but non-elective operation (HR1.4, 95% CI 1.11 - 1.77, p < 0.001) and NYHA class III/IV (HR1.03, 95% CI 1.32 - 1.70, p = 0.03) were. Conclusions: Diabetics more often presented for non-elective CABG with advanced symptoms, impaired left ventricular function, prior myocardial infarction and coronary stenting. Advanced symptoms contributed to higher MACCE rates in diabetics. Diabetic patients should be referred early for surgery.
References
[1]
Rodriguez-Araujo, G. and Nakagami, H. (2018) Pathophysiology of Cardiovascular Disease in Diabetes Mellitus. CardiovascularEndocrinology&Metabolism, 7, 4-9. https://doi.org/10.1097/xce.0000000000000141
[2]
Number of People Living with Diabetes in the UK Tops 5 Million for the First Time. https://www.diabetes.org.uk/about_us/news/number-people-living-diabetes-uk-tops-5-million-first-time#:~:text=Our%20new%20figures%20show%20that,2%20diabetes%20in%20the%20UK
[3]
Dokken, B.B. (2008) The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids. DiabetesSpectrum, 21, 160-165. https://doi.org/10.2337/diaspect.21.3.160
[4]
Detre, K.M., Guo, P., Holubkov, R., Califf, R.M., Sopko, G., Bach, R., et al. (1999) Coronary Revascularization in Diabetic Patients: A Comparison of the Randomized and Observational Components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation, 99, 633-640. https://doi.org/10.1161/01.cir.99.5.633
[5]
EL-Andari, R., Bozso, S.J., Fialka, N.M., Kang, J.J.H., Nagendran, J. and Nagendran, J. (2022) Coronary Revascularization for Patients with Diabetes Mellitus: A Contemporary Systematic Review and Meta-Analysis. AnnalsofSurgery, 275, 1058-1066. https://doi.org/10.1097/sla.0000000000005391
[6]
Jaiswal, V., Sattar, Y., Peng Ang, S., Ishak, A., Naz, S., Minahil Nasir, Y., et al. (2023) Long Term Outcomes of Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus with Multi Vessels Diseases: A Meta-Analysis. IJCHeart&Vasculature, 46, Article ID: 101185. https://doi.org/10.1016/j.ijcha.2023.101185
[7]
Rajakaruna, C., Rogers, C.A., Suranimala, C., Angelini, G.D. and Ascione, R. (2006) The Effect of Diabetes Mellitus on Patients Undergoing Coronary Surgery: A Risk-Adjusted Analysis. TheJournalofThoracicandCardiovascularSurgery, 132, 802-810. https://doi.org/10.1016/j.jtcvs.2006.05.056
[8]
Risnes, I., Abdelnoor, M., Almdahl, S.M. and Svennevig, J.L. (2010) Mediastinitis after Coronary Artery Bypass Grafting Risk Factors and Long-Term Survival. TheAnnalsofThoracicSurgery, 89, 1502-1509. https://doi.org/10.1016/j.athoracsur.2010.02.038
[9]
He, L., Liu, M., He, Y. and Guo, A. (2023) Impact of Diabetic versus Non‐Diabetic Patients Undergoing Coronary Artery Bypass Graft Surgery on Postoperative Wound Complications: A Meta‐Analysis. InternationalWoundJournal, 21, e14495. https://doi.org/10.1111/iwj.14495
[10]
Santos, K.A.Q., Berto, B., Sousa, A.G. and Costa, F.A.A.d. (2015) Prognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery. BrazilianJournalofCardiovascularSurgery, 31, 7-14. https://doi.org/10.5935/1678-9741.20160002
[11]
Morricone, L., Ranucci, M., Denti, S., Cazzaniga, A., Isgrò, G., Enrini, R., et al. (1999) Diabetes and Complications after Cardiac Surgery: Comparison with a Non-Diabetic Population. ActaDiabetologica, 36, 77-84. https://doi.org/10.1007/s005920050149
[12]
Ngaage, D.L., Jamali, A.A., Griffin, S., Guvendik, L., Cowen, M.E. and Cale, A.R. (2009) Non-Infective Morbidity in Diabetic Patients Undergoing Coronary and Heart Valve Surgery. EuropeanJournalofCardio-ThoracicSurgery, 35, 255-259. https://doi.org/10.1016/j.ejcts.2008.08.009
[13]
Zhang, X., Wu, Z., Peng, X., Wu, A., Yue, Y., Martin, J., et al. (2011) Prognosis of Diabetic Patients Undergoing Coronary Artery Bypass Surgery Compared with Nondiabetics: A Systematic Review and Meta-Analysis. JournalofCardiothoracicandVascularAnesthesia, 25, 288-298. https://doi.org/10.1053/j.jvca.2010.09.021
[14]
Antunes, P.E., de Oliveira, J.F. and Antunes, M.J. (2008) Coronary Surgery in Patients with Diabetes Mellitus: A Risk-Adjusted Study on Early Outcome. EuropeanJournalofCardio-ThoracicSurgery, 34, 370-375. https://doi.org/10.1016/j.ejcts.2008.05.008